Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials
- Author(s):
- Dowsett, M.; Forbes, J.F.; Bradley, R.; Ingle, J.; Aihara, T.; Bliss, J.; Boccardo, F.; Coates, A.; Coombes, R.C.; Cuzick, J.; Dubsky, P.; Gnant, M.; Kaufmann, M.; Kilburn, L.; Perrone, F.; Rea, D.; Thurlimann, B.; Velde, C. van de; Pan, H.; Peto, R.; Davies, C.; Gray, R.; Baum, M.; Buzdar, A.; Sestak, I.; Markopoulos, C.; Fesl, C.; Jakesz, R.; Colleoni, M.; Gelber, R.; Regan, M.; Minckwitz, G. von; Snowdon, C.; Goss, P.; Pritchard, K.; Anderson, S.; Costantino, J.; Mamounas, E.; Ohashi, Y.; Watanabe, T.; Bastiaannet, E.; Early Breast Canc Trialists
- Published
- 2015
- Publication type
- Article / Letter to editor
- Date issued
- 2015-10-03
- Language
- English
- Is part of
- Lancet (2015), Vol. 386, no. 10001, p. 1341-1352
- hdl
- 1887/101141
- doi
- 10.1016/S0140-6736(15)61074-1